CBT vs Medication for Anxiety: What Head-to-Head Trials Actually Show
What head-to-head trials of CBT vs medication for anxiety actually show, why comparing them is harder than it sounds, and what the evidence leaves open.
What head-to-head trials of CBT vs medication for anxiety actually show, why comparing them is harder than it sounds, and what the evidence leaves open.
How large the placebo response is in anxiety trials, what drives it, and why it matters for reading treatment results honestly.
How exposure therapy for anxiety is studied, what trials actually measure, and why researchers still debate the mechanism behind one of the best-supported treatments.
Correlation vs causation in anxiety research: why a link isn’t proof, and how follow-up studies, trials and genetic designs get closer to cause.
What research shows about expressive writing and journaling for anxiety, what the original Pennebaker studies found, and why the effects are smaller than commonly claimed.
Why a plausible mechanism isn’t proof something eases anxiety: animal-to-human gaps, surrogate outcomes, and how GABA, magnesium and probiotics compare.
What the nocebo effect is, how large it is in anxiety medication trials, how it affects dropout and outcomes, and what informed consent approaches might reduce it.
How sleep and anxiety influence each other, why the causal direction is hard to establish, and what intervention studies show about breaking the cycle.
How much treatment outcome depends on which therapist delivers it, what research shows about therapist variability, and what this means for anxiety treatment trials and practice.
What transdiagnostic treatments for anxiety are, the evidence from comparative trials, whether they match disorder-specific CBT, and what the practical trade-offs are.